CD38 and Miyoshi myopathy: In order to speculate on the potential effect of anti-CD38 antibodies in AL amyloidosis, the mechanisms through which DARA (the most analyzed anti-CD38 agent) exerts its cytotoxic role on effector cells in MM (that is mainly mediated by anFcR-dependent mechanism) should be mentioned.